Cargando…

Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?

Dopamine is a neurotransmitter that mediates neuropsychological functions of the central nervous system (CNS). Recent studies have shown the modulatory effect of dopamine on the cells of innate and adaptive immune systems, including Th17 cells, which play a critical role in inflammatory diseases of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melnikov, Mikhail, Pashenkov, Mikhail, Boyko, Alexey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157879/ https://www.ncbi.nlm.nih.gov/pubmed/34070011 http://dx.doi.org/10.3390/ijms22105313

Ejemplares similares

The Role of D(2)-like Dopaminergic Receptor in Dopamine-mediated Modulation of Th17-cells in Multiple Sclerosis
por: Melnikov, Mikhail, et al.
Publicado: (2022)

Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis
por: Dubchenko, Ekaterina, et al.
Publicado: (2020)

Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapy
por: Melnikov, Mikhail, et al.
Publicado: (2022)

Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies
por: Boyko, Alexey, et al.
Publicado: (2020)

The Dual Role of the β(2)-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple Sclerosis
por: Melnikov, Mikhail, et al.
Publicado: (2022)

The influence of glatiramer acetate on Th17-immune response in multiple sclerosis
por: Melnikov, Mikhail, et al.
Publicado: (2020)

Th17-cells in depression: Implication in multiple sclerosis
por: Melnikov, Mikhail, et al.
Publicado: (2022)

Neuropeptide Receptors: Novel Targets for HIV/AIDS Therapeutics
por: Branch, Donald R.
Publicado: (2011)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis
por: Grieb, Paweł, et al.
Publicado: (2021)

The importance of collecting structured clinical information on multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Pumping iron: a potential target for novel therapeutics against schistosomes
por: Glanfield, Amber, et al.
Publicado: (2007)

Glatiramer acetate in the treatment of multiple sclerosis
por: Tselis, Alex, et al.
Publicado: (2007)

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
por: Govindarajan, Vaidya, et al.
Publicado: (2020)

Therapeutics through glycobiology: an approach for targeted elimination of malaria
por: Divya, Mallya, et al.
Publicado: (2023)

Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

The role of glatiramer acetate in the early treatment of multiple sclerosis
por: Brandes, David W
Publicado: (2010)

Protein kinase Cα: disease regulator and therapeutic target
por: Konopatskaya, Olga, et al.
Publicado: (2010)

Q&A: targeting autophagy in cancer—a new therapeutic?
por: White, Eileen
Publicado: (2014)

Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
por: Kim, Dong Eun, et al.
Publicado: (2020)

Cladribine tablets’ potential role as a key example of selective immune reconstitution therapy in multiple sclerosis
por: Boyko, Alexey N, et al.
Publicado: (2018)

Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics
por: Morris, Gerwyn, et al.
Publicado: (2013)

Pediatric multiple sclerosis: a review
por: Alroughani, Raed, et al.
Publicado: (2018)

Targeting the metabolism of leukemia stem cells as a novel therapeutic strategy
por: Ho, Emmanuel A, et al.
Publicado: (2013)

Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role
por: Samuel, Samson Mathews, et al.
Publicado: (2021)

Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
por: Edan, Gilles, et al.
Publicado: (2013)

Potentially Common Therapeutic Targets for Multiple Sclerosis and Ischemic Stroke
por: Paternò, Roberto, et al.
Publicado: (2018)

Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
por: Berk, Michael, et al.
Publicado: (2013)

S1 Subunit and Host Proteases as Potential Therapeutic Avenues for the Treatment of COVID-19
por: Arafah, Azher, et al.
Publicado: (2020)

Inevitability of the emergence and persistence of genetic parasites caused by evolutionary instability of parasite-free states
por: Koonin, Eugene V., et al.
Publicado: (2017)

Stem Cells Therapy in Multiple Sclerosis - A New Hope for Progressive Forms
por: Ayache, Samar S., et al.
Publicado: (2016)

CPP-ZFN: A potential DNA-targeting anti-malarial drug
por: Nain, Vikrant, et al.
Publicado: (2010)

Review of the clinical evidence for interferon β 1a (Rebif(®)) in the treatment of multiple sclerosis
por: Manfredonia, Francesco, et al.
Publicado: (2008)

Evidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis
por: Londoño, Ana C., et al.
Publicado: (2017)

Thyroid (Dys)Function in Heart Failure: Is it a Potential Target for Medical Treatment?
por: Pingitore, Alessandro, et al.
Publicado: (2005)

Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution
por: Land, Walter Gottlieb
Publicado: (2020)

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
por: Tan, Yossan-Var, et al.
Publicado: (2011)

Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
por: Hoenig, Michel R
Publicado: (2008)

Beyond Ion Homeostasis: Hypomagnesemia, Transient Receptor Potential Melastatin Channel 7, Mitochondrial Function, and Inflammation
por: Liu, Man, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_festl9ogru3if6taci2sr48mit